Blending of Shenling Baizhu Powder Veterinary Grade API into tablet cores requires prior particle-size reduction because the as-supplied botanical matrix contains lignified stem fragments and polysaccharide-rich aggregates that cause weight variation under high-speed compression. The powder is passed through a 60-mesh (250 µm) stainless-steel sieve before charging into a high-shear granulator at 65–75% of bowl volume. Dry blending with 20–40 wt% microcrystalline cellulose and 5–10 wt% crospovidone is performed for 3–5 minutes at impeller speed 150–250 rpm and chopper speed 1500–2500 rpm. A binder solution of 5 wt% povidone K30 in 50% ethanol or 3 wt% hypromellose E5 in water is sprayed at 10–20 g/min/kg dry mass. Granulation endpoint is taken when power draw or torque rises 15–25% above dry-mix baseline and the wet mass forms agglomerates of 1–3 mm. Drying is performed in a fluid-bed dryer with inlet air 55–65 °C and product temperature 38–42 °C until loss on drying reaches 2.5–4.0%; over-drying below 2.0% increases tablet capping because amorphous polysaccharides in the matrix become brittle. Milled granules are passed through a 0.8–1.2 mm conical mill screen and blended with 0.5–1.0 wt% magnesium stearate and 0.5–1.5 wt% colloidal silicon dioxide for 2–3 minutes. Compression on a 27-station rotary tablet press uses precompression force 8–12 kN and main compression force 25–40 kN, targeting hardness 60–100 N, friability below 1.0% under Ph. Eur. 2.9.7, and disintegration below 30 minutes under Ph. Eur. 2.9.1. The tablet strength is declared as weight of Shenling Baizhu Powder veterinary grade per unit rather than as a single isolated marker. Process validation follows FDA 21 CFR Part 210/211, and stability storage follows VICH GL18 at 25 ± 2 °C and 60 ± 5% RH for climatic zone II. The hygroscopic matrix requires packaging in aluminium-PVC-PVDC blister film with moisture vapour transmission rate below 0.1 g/m²/day at 38 °C and 90% RH to prevent softening and colour change.

What Filtration Load Can a 10% Botanical Extract Feed Sustain Before 0.22 µm Membrane Fouling?

Injectable processing of Shenling Baizhu Powder Veterinary Grade API is performed on a clarified aqueous extract rather than by suspending raw powder, because the botanical polysaccharides and triterpene glycosides act as colloidal foulants in sterilising-grade filtration. The extraction vessel is charged with powder and Water for Injection at 1:10 to 1:20 w/v, heated to 80–90 °C for 1–2 hours under reflux, then cooled to 40 °C before clarification. Centrifugation at 10,000–14,000 × g for 15–30 minutes removes coarse cell debris; the supernatant is polished through a 0.45 µm polyethersulfone membrane at a transmembrane pressure below 0.5 bar to avoid compacting the polysaccharide gel layer. Intermediate solution should show turbidity below 10 NTU and total solids 2–5% w/v; higher solids feeds shorten throughput and require a glass-fibre prefilter. The filtration load per 0.1 m² of membrane area is commonly limited to 20–40 L for a 10% extract feed before differential pressure exceeds 1.0 bar, but published data for this specific formula are limited and filterability trials should be repeated for each botanical lot. The filtered solution is filled into Type I glass vials under EU GMP Annex 1 grade A with ISO 14644-1 Class 5 conditions and grade B background; terminal sterilisation at 121 °C for 15 minutes is used where marker stability permits. If the atractylenolide marker degrades more than 5% under thermal load, aseptic filtration without terminal sterilisation is required. pH is adjusted to 5.5–7.5 with 0.1 M sodium hydroxide or hydrochloric acid. Particulate matter must meet Ph. Eur. 2.9.19: not more than 6000 particles ≥10 µm and 600 particles ≥25 µm per container. Endotoxin is controlled by the dose-based limit and Water for Injection is monitored below 0.25 EU/mL. The final injectable is presented as 10 mL or 50 mL vials. Polysorbate 80 above 0.2% may solubilise hydrophobic markers but can reduce the zeta potential of colloidal residuals and increase subvisible particles during storage at 40 °C; compatibility must be tested by flow imaging.

Hard Capsule Fill Weight Uniformity Without Excipient Overhead

Direct encapsulation of as-supplied Shenling Baizhu Powder Veterinary Grade API in hard gelatin or hypromellose capsules is generally unsuitable because the powder exhibits low bulk density and high cohesion; Hausner ratio values above 1.35 and Carr index above 30 predict fill weight deviations beyond 5% on auger and tamping-pin machines. Dry granulation by slugging or roller compaction raises tapped density to 0.55–0.70 g/mL and brings the Hausner ratio below 1.25. A practical capsule formulation contains 30–50 wt% of the active powder, 20–40 wt% microcrystalline cellulose, 10–20 wt% lactose monohydrate, 2–5 wt% crospovidone, and 0.5–2 wt% colloidal silicon dioxide. The blend is compacted on a roller compactor with roll pressure 4–8 kN/cm, roll speed 2–5 rpm, and granulator screen 0.8–1.25 mm. Granules are filled into size 0 or 00 capsules using a tamping-pin machine with pin height 12–18 mm and target fill mass 500 mg or 1000 mg. Fill weight uniformity is assessed on 20 capsules with average deviation ±5% and individual deviation below 7.5%. In-process moisture is maintained at 3–5% for hypromellose capsules and 4–6% for gelatin capsules; below 3% hypromellose shells may crack at the locking ring, while above 6% the powder may swell and delay disintegration beyond 30 minutes under Ph. Eur. 2.9.1. Disintegration is performed in 900 mL water at 37 ± 1 °C with discs; crospovidone below 2 wt% often fails because the polysaccharide fraction forms a gel plug. Dissolution testing under USP <711> or Ph. Eur. 2.9.3 with Apparatus 2 at 50 rpm paddle speed and 0.1 M hydrochloric acid may track marker release. The terminal capsule product is packed in HDPE bottles with heat-induction seals and desiccant; storage above 25 °C and 60% RH can reduce dissolution rate because moisture transfers from the shell into the powder.

In drinking-water medication, the Shenling Baizhu Powder Veterinary Grade API is milled or micronised to a median particle size D50 below 75 µm and D90 below 150 µm, because larger particles settle in standing water lines and create uneven dose intake in poultry and swine barns. Mechanical milling with a classifier speed of 10,000–15,000 rpm is used after the coarse powder is pre-sieved through an 80-mesh screen, since hard stem fragments can blind the mill screen. The milled powder is blended with anhydrous dextrose or lactose monohydrate at 1:5 to 1:20 w/w in a ribbon blender or V-blender at 50–70% nominal volume for 15–25 minutes; assay uniformity from 10 sampling points should show relative standard deviation below 5%. Sodium citrate or citric acid at 0.5–1.0 wt% is included to chelate calcium and magnesium in hard water, because divalent cations above 200 ppm as CaCO₃ can flocculate acidic polysaccharides and block proportioner medicators set at 1:100 or 1:1000 stock solutions. The finished powder should disperse in water at 25 °C within 5 minutes; persistent foam may be controlled with simethicone at 0.01–0.05%, but deaeration is required before sachet filling to avoid weight variation. Sachet sizes range from 100 g to 1 kg; packaging uses PET-Al-LDPE laminate with moisture vapour transmission rate below 0.5 g/m²/24 h at 38 °C and 90% RH because the milled powder is more hygroscopic than the coarse API. Stability is tested under VICH GL18 at 30 °C/65% RH for 12–24 months; real-time data are generated because accelerated conditions can overstate colour change in botanical powders.

When Fluid-Bed Spray Agglomeration Replaces Wet Mass Extrusion for In-Feed Granules

Fluid-bed granulation of Shenling Baizhu Powder Veterinary Grade API is selected when in-feed granules require low dust generation and controlled bulk density rather than fast reconstitution. A top-spray fluid-bed granulator with inlet air temperature 50–70 °C and exhaust air temperature 30–40 °C is charged with the API premixed with lactose or mannitol at 1:1 to 1:4 w/w. Binder solution of 3–5 wt% povidone K30 or 2–4 wt% hypromellose in water is sprayed at 10–30 g/min/kg bed material with atomising air pressure 1.0–2.5 bar. Spraying above 30 g/min/kg causes local over-wetting, bed collapse, and granules with hard outer shells and wet cores. Granule size is controlled by sieve classification to 0.2–0.8 mm with D50 between 400 µm and 600 µm; oversized granules above 0.8 mm are not simply recycled because their higher binder content increases segregation during feed addition. Loss on drying after granulation should be 2.5–4.0%; moisture below 2.0% raises fines during conveying, while moisture above 5.0% supports mould growth in non-protected warehouse conditions. The finished granule shows bulk density 0.45–0.65 g/mL, tapped density 0.55–0.75 g/mL, and Carr index below 20. Sieve analysis is conducted according to Ph. Eur. 2.9.38 using 200 mm diameter test sieves; a mass balance below 98% indicates hygroscopic bridging of sieve apertures and requires condensation checks before retesting. Granules are filled into metallised film pouches or polyethylene-lined multiwall paper sacks at 500 g, 1 kg, or 5 kg. Batch-to-batch variation in the botanical raw material changes the glass transition of the aqueous binder film; sorption isotherms at 25 °C and 50–80% RH should be generated for each new crop lot to set the spray rate and avoid product sticking on filter bags.

Premix Uniformity Depends on Stepwise Geometric Dilution and Carrier Particle Size

A 1:100 or 1:1000 medicated premix for feed mills is manufactured by first passing the Shenling Baizhu Powder Veterinary Grade API through a 60-mesh screen and blending it with an equal weight of calcium carbonate, rice hulls, or corn cob carrier in a low-shear mixer for 5 minutes. This first pre-blend is then diluted in steps no larger than 1:10 per stage; geometric dilution in at least three stages is required because active assay variability above 10% RSD appears when total carrier is added at once in a ribbon mixer with insufficient shear. Final mixing is performed in a horizontal ribbon mixer at 60–70% fill volume for 10–20 minutes; mixing beyond 25 minutes is not beneficial because electrostatic charge and particle size differences between botanical powder and mineral carriers can promote re-segregation. Target carrier particle size is 200–500 µm with not more than 5% passing 100 µm, because fine dust competes for moisture and causes API adhesion to mixer walls. Mineral oil or vegetable oil at 0.5–2.0 wt% of the final premix is sprayed after the active blend is uniform to suppress dust and reduce carryover in feed mill conveying lines; oil addition above 2.5 wt% can swell the botanical powder, raise water activity above 0.65, and create mould risk. The finished premix should have coefficient of variation below 5% for marker assay on 10 thief samples, with individual sample deviation below 10%. United States medicated feed operations are handled under FDA 21 CFR Part 225 and 226; in the EU, feed business operators apply GMP+ BA2 or FAMI-QS principles for botanical feed materials. Heavy metal and pesticide limits must be confirmed against the relevant regional feed material monograph. Packaging is in 20 kg or 25 kg multi-wall paper sacks with polyethylene liner; storage below 30 °C and below 65% RH is specified because the premix absorbs moisture faster than granules or tablets.

Aqueous oral solutions prepared from Shenling Baizhu Powder Veterinary Grade API require a clarified liquid extract, unless the veterinary product is registered as a suspension. Extraction is performed with purified water at 60–80 °C for 1–2 hours, followed by filtration through 10 µm and 1 µm depth filters; the final extract is concentrated to dry matter content 2–5% w/v. The solution pH is adjusted to 5.0–7.0; below pH 4.0 acidic polysaccharides precipitate, while above pH 8.0 the extract darkens and microbial growth risk increases before preservative addition. Methyl paraben at 0.1% and propyl paraben at 0.02% are dissolved in propylene glycol or hot water before addition; benzoic acid at 0.05–0.1% may be used if pH is maintained below 5.5, but benzoate salts above 0.2% can salt out the polysaccharide fraction. Sodium metabisulfite at 0.02–0.1% is included if the solution contains oxygen-sensitive marker compounds, but it must not be combined with chlorhexidine or other oxidising preservatives because sulfite reduces antimicrobial activity. The finished solution is filled into amber PET or glass bottles with child-resistant closures; dissolved oxygen in the headspace is reduced below 2 ppm by nitrogen flushing, and fill volume tolerance is ±1.5% for 100 mL, 250 mL, and 500 mL presentations. Viscosity should remain below 20 mPa·s at 25 °C for dosing pumps and oral drench guns; a viscosity above 30 mPa·s may indicate Maillard browning from residual reducing sugars, and the batch is controlled by colorimetric testing at 420 nm if the specification includes colour. Microbial limits follow Ph. Eur. 5.1.4 for oral liquids: total aerobic microbial count below 10² CFU/mL and absence of Escherichia coli in 1 mL; preservative efficacy testing under Ph. Eur. 5.1.3 is required because botanical polyphenols can bind parabens and reduce free preservative levels below the minimum inhibitory concentration.